Your browser doesn't support javascript.
loading
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.
Roberts, Matthew J; Conduit, Ciara; Davis, Ian D; Effeney, Rachel M; Williams, Scott; Martin, Jarad M; Hofman, Michael S; Hruby, George; Eapen, Renu; Gianacas, Chris; Papa, Nathan; Lourenço, Richard De Abreu; Dhillon, Haryana M; Allen, Ray; Fontela, Antoinette; Kaur, Baldeep; Emmett, Louise.
Affiliation
  • Roberts MJ; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
  • Conduit C; Royal Brisbane and Women's Hospital, Herston, Qld, Australia.
  • Davis ID; Redcliffe Hospital, Redcliffe, Qld, Australia.
  • Effeney RM; Faculty of Medicine, Centre for Clinical Research, The University of Queensland, Brisbane, Qld, Australia.
  • Williams S; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
  • Martin JM; Walter and Eliza Hall Institute of Medical Research, Melbourne, Vic., Australia.
  • Hofman MS; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
  • Hruby G; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.
  • Eapen R; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
  • Gianacas C; Department of Medical Oncology, Eastern Health, Box Hill, Vic., Australia.
  • Papa N; Monash University Eastern Health Clinical School, Box Hill, Clayton, Vic., Australia.
  • Lourenço RA; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
  • Dhillon HM; Royal Brisbane and Women's Hospital, Herston, Qld, Australia.
  • Allen R; Redcliffe Hospital, Redcliffe, Qld, Australia.
  • Fontela A; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.
  • Kaur B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.
  • Emmett L; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
BJU Int ; 133 Suppl 3: 39-47, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37604702
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Country/Region as subject: Oceania Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2024 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Country/Region as subject: Oceania Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2024 Type: Article Affiliation country: Australia